Vestibular schwannomas treated with Cyberknife®: clinical outcomes.

Date publication

décembre 2016

Journal

Tumori

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie , Pr PEIFFERT Didier

Tous les auteurs :
Jumeau R, Bondiau PY, Parietti-Winkler C, Salleron J, Civit T, Peiffert D, Bernier-Chastagner V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27716876

Résumé

Fractionated stereotactic radiotherapy (FSR) is a recognized treatment for vestibular schwannomas (VS). This study's aim is to present clinical outcomes and local control (LC) results for patients with VS treated with FSR using the Cyberknife® (CK) in 2 French cancer centers.

Mots clés

Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Dose Fractionation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuroma, Acoustic, mortality, Radiation Dosimeters, Radiosurgery, adverse effects, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Retrospective Studies, Treatment Outcome, Tumor Burden, Young Adult

Référence

Tumori. 2016 Dec;102(6):569-573